TEMPLATE

Leaders in Learning: Publications of Faculty & Staff

Oncology: 2000-2001

BATTISTA, J.J.

Karnas, S.J., N. Avvakumov, E. Yu, and J.J. Battista. 2001. Operational characteristics of a prototype x-ray needle device. Physics in Medicine and Biology 46 (1): 97-106.

Lindsay, P., J.J. Battista, and J. Van Dyk. 2001. The effect of seed anisotrophy on brachytherapy dose distributions using 125I and 103Pd. Medical Physics 28 (3): 336-345.

Moiseenko, V., J. Van Dyk, J.J. Battista, and E. Travis. 2000. Limitations in using dose-volume histograms for radiotherapy dose optimization. The Use of Computers in Radiation Therapy. Heidelberg, Germany: Springer-Verlag. 239-241.

Van Dyk, J., and J.J. Battista. 2000. The Cobalt-60 Challenge. MDS Nordion's Teletherapy Products Newsletter 2 (1)

BAUMAN, G.S.

Bauman, G.S., and D.J. Bochinski. 2000. Simulation for localized prostate cancer: a comparison of urethrography techniques. Medical Dosimetry 25 (3): 145-148.

Bauman, G.S., and J.G. Cairncross. 2001. Multidisciplinary management of adult anaplastic oliogodendrogliomas and anaplastic mixed oligo-astrocytomas. Seminars in Radiation Oncology 11 (2): 170-180.

Bauman, G.S., Y. Ino, K. Ueki, M.C. Zlatescu, B.J. Fisher, D.R. Macdonald, L. Stitt, D.N. Louis, and J.G. Cairncross. 2000. Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas. International Journal of Radiation Oncology Biology Physics 48 (3): 825-830.

Bauman, G.S., J. Xuan, J. Chin, H. Sakai, Y. Guo, S. Garde, J. Fraser, and V.M. Venkatesan. 2000. Evaluation of prognostic utility in patients treated with radiotherapy for nonmetastatic prostate cancer. The Prostate Journal 2 (2 ): 94-101.

Fisher, B.J., E. Naumova, N. Kerkuliet, A.F. Chambers, D. Fortin, C. Leighton, D.R. Macdonald, J.G. Cairncross, G.S. Bauman, and L. Stitt. 2000. Is K1-67 a Prognostic Factor for LGGlioma. Journal of Neuro-Oncology 2 (3): 197-198.

Greenland, J.D., G.S. Bauman, E. Winquist, and R.R. Shepherd. 2000. Palliative chemoirradiation for transitional carcinoma of the bladder: a case report. The Canadian Journal of Urology 7 (4): 1085-1087.

BRAMWELL, V.H.

Bramwell, V.H. 2001. Adjuvant chemotherapy for adult soft tissue sarcoma: Is there a standard of care? Journal of Clinical Oncology 19 (5): 1235-1237.

Bramwell, V.H. 2000. Osteosarcomas and other cancers of bone. Current Opinion in Oncology 12 (4): 330-336.

Gortzak, E., A. Azzarelli, J. Buesa, V.H. Bramwell, C.F. van, G.AN. van, A. Ezzat, A. Santoro, J.W. Oosterhuis, M. van Glabbeke, A. Kirkpatrick, J. Verweij, and others. 2001. A randomized phase II study on neo-adjuvant chemotherapy for high-risk adult soft-tissue sarcoma. European Journal of Cancer 37 (9): 1096-1103. The E.O.R.T.C. Soft Tissue Bone Sarcoma Group and the National Cancer Institute of Canada Clinical Trials Group/Canadian Sarcoma Group.

Vincent, M.D., V.H. Bramwell, LA. Moran, D. Anderson, and CCO PGI Systemic Treatment Disease Site Group. 2000. Use of amifostine to ameliorate the toxic effects of chemotherapy in the treatment of cancer. Current Oncology Reports 7 (3 ): 149-161.

CAIRNCROSS, J.G.

Cairncross, J.G., L. Swinnen, R. Bayer, S. Rosenfeld, D. Salzman, N. Paleologos, L. Kaminer, P. Forsyth, D. Stewart, K. Peterson, D.R. Macdonald, D. Ramsay, A. Smith, W. Hu, and Oligodendroglioma Study Group. 2000. Myeloablative chemotherapy for recurrent aggressive oligodendroglioma. Journal of Neuro-Oncology 2 (2): 114-119.

DeAngelis, L.M., and J.G. Cairncross. H.D. Humes, H.L. DuPont, and L.B. Gardner. 2000. Approach to the patient with tumors of the central nervous system. Kelly's Textbook of Internal Medicine. 4th ed. Philadelphia: Lippincott. 2846-2854 pp.

Doolittle, N.D., C.P. Anderson, W.A. Bleyer, J.G. Cairncross, T. Cloughesy, S. Eck, P. Guastadisegni, W.A. Hall, L.L. Muldoon, S.J. Patel, D. Peereboom, T. Siegal, and E.A. Neuwelt. 2000. Importance of dose-intensity in neuro-oncology clinical trials. Neuro-Oncology 3 (1): 46-54.

Glantz, M.J., B.F. Cole, P.A. Forsyth, L.D. Recht, P.Y. Wen, M.C. Chamberlain, S.A. Grossman, and J.G. Cairncross. 2000. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the Amercian Academy of Neurology. Neurology 54 (10): 1886-1893.

Ino, Y., R.A. Betensky, M.C. Zlatescu, H. Sasaki, D.R. Macdonald, A.O. Stemmer-Rachamimov, D.A. Ramsay, J.G. Cairncross, and D.N. Louis. 2001. Molecular subtypes of anaplastic oligodendroglioma: implications for patients management at diagnosis. Clinical Cancer Research 7 (4): 839-845 .

Nutt, C.L., M. Noble, A.F. Chambers, and J.G. Cairncross. 2000. Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy. Cancer Research 60 (17): 4812-4818.

Xu, G.W., C.L. Nutt, M.C. Zlatescu, M. Keeney, I. Chin-Yee, and J.G. Cairncross. 2001. Intactivation of p53 sensitizes U87MGS glioma cells to 1,3-Bis (2-chloroethyl)-1-nitrosourea. Cancer Research 61 (10): 4155-4159.

Zlatelscu, M.C., A. TehraniYazdi, H. Sasaki, J.F. Megyesi, R.A. Betensky, D.N. Louis, and J.G. Cairncross. 2001. Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. Cancer Research 61 (18): 6713-6715.

CHAMBERS, A.F.

Cameron, M.D., E.E. Schmidt, N. Kerkvliet, K.V. Nadkarni, V.L. Morris, A.C. Groom, A.F. Chambers, and I.C. MacDonald. 2000. Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Research 60 (9): 2541-2546.

Chambers, A.F., I.C. MacDonald, E.E. Schmidt, V.L. Morris, and A.C. Groom. 2000. Clinical targets for anti-metastasis therapy. Advances in Cancer Research (79): 91-121.

Chambers, A.F., G.N. Naumov, S.A. Vantyghem, and A.B. Tuck. 2000. Molecular biology of breast cancer metastasis: clinical implications of experimental studies on metastatic inefficiency. Breast Cancer Research 2 (6): 400-407.

Chambers, A.F., G.N. Naumov, H.J. Varghese, K.V. Nadkarni, I.C. MacDonald, and A.C. Groom. 2001. Critical steps in hematogenous metastasis: an overview. Surgical Oncology Clinics of North America 10 (2): 243-255 vii.

Chiba. S., M.M. Rashid, H. Okamoto, H. Shiraiwa, S. Kon, M. Maeda, M. Murakami, M. Inobe, A. Kitabatake, A.F. Chambers, and T. Uede. 2000. The role of osteopontin in the development of granulomatous lesions in lung. Microbiology and Immunology 44 (4): 319-332.

Harris, N.L., K.R. Rattray, T.M. Underhill, M.J. Somerman, J.A. D'Errico, A.F. Chambers, G.K. Hunter, and H.A. Goldberg. 2000. Functional analysis of bone sialoprotein: identification of the hydroxyapatite-nucleating and cell-binding domains by recombinant peptide expression and site-directed mutagenesis. Bone 27 (6): 795-802.

Mello, M.L., A.F. Chambers, B.C. Vidal, W. Planding, and U. Schenck. 2000. Restriction enzyme analysis of DNA methylation in condensed chromatin of Ha-ras-transformed NIH 3T3 cells. Analytical Cellular Pathology 20 (4): 163-171.

DAR, R.

Bedard, E.L., R.I. Inculet, R.A. Malthaner, E. Brecevic, M.D. Vincent, and R. Dar. 2001. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma. Cancer 91 (12): 2423-2430.

DIMATTIA, G.E.

Deol, H.K., R. Varghese, G.F. Wagner, and G.E. DiMattia. 2000. Dynamic regulation of mouse ovarian stanniocalcin expression during gestation and lactation. Endocrinology 141 (9): 3412-3421.

Stasko, S.E., G.E. DiMattia, and G.F. Wagner. 2001. Dynamic changes in stanniocalcin gene expression in the mouse uterus during early implantation. Molecular and Cellular Endocrinology 174 (1-2): 145-149.

FISHER, B.J.

DelRowe, J., C. Scott, Werner-Wasik, J. Bahary, W. Curran, R. Urtasun, and B.J. Fisher. 2000. Single Arm Open Label Phase II Study of IV Administered Tirapazamine & Radiation for Glioblastoma. JCO (18): 1254-1259.

Fisher, B.J., C. Scott, D.R. Macdonald, C. Coughlin, and W.J. Curran. 2001. Phase I study of topotecan plus cranial radiation for glioblastoma multiforme: results of Radiation Therapy Oncology Group Trial 9507. Journal of Clinical Oncology 19 (4): 1111-1117.

Leighton, C., B.J. Fisher, and F. Perera. 2001. Acute radiation proctitis. Lancet 357 (9252:306): 306-307.

GILCHRIST, J.

Tai, P.T., E. Yu, J. Tonita, and J. Gilchrist. 2000. Merkel Cell Carcinoma of the Skin. Journal of Cutaneous Medicine and Surgery 4 (4): 186-195.

HAMMOND, A.

Tai, P., A. Hammond, J.V. Dyk, L. Stitt, J. Tonita, T. Coad, and J. Radwan. 2000. Pelvic fractures following irradiation of endometrial and vaginal cancers - a case series and review of the literature. Radiotherapy and Oncology 56 (1): 23-28.

HAMMOND, G.L

Avvakumov, G.V., Y.A. Muller, and G.L. Hammond. 2000. Steroid-binding specificity of human sex hormone-binding globulin is influenced by occupancy of zinc-binding site. Journal of Biological Chemistry 275 (34): 25920-25925.

Fielden, M.R., Z.F. Wu, C.J. Sinal, H. Hodgert Jury, J.R. Bend, G.L. Hammond, and T.R. Zacharewski. 2000. Estrogen receptor-and aryl hydrocarbon receptor-mediated activities of a coal-tar creosote. Environmental Toxicology and Chemistry 19: 1262-1271.

Hodgert Jury, H., T.R. Zacharewski, and G.L. Hammond. 2000. Interactions between human plasma sex hormone-binding globulin and xenobiotic ligands. Journal of Steroid Biochemistry and Molecular Biology 75 (2-3): 167-176.

Hogeveen, K.N., M. Talikka, and G.L. Hammond. 2001. Human sex hormone-binding globulin promoter activity is influenced by a (TAAAA)n repeat element within an Alu sequence. Journal of Biological Chemistry 276 (39): 36383-36390.

KOROPATNICK, D.J.

DeMoor, J.M., and D.J. Koropatnick. 2000. Metals and cellular signaling in mammalian cells. Cellular and Molecular Biology 46 (2): 367-381.

Imasato, Y., T. Onita, M. Moussa, H. Sakai, F.L. Chan, D.J. Koropatnick, J.L. Chin, and J.W. Xuan. 2001. Rodent PSP94 gene expression is more specific to the dorsolateral prostate and less sensitive to androgen ablation that probasin. Endocrinology 142 (5): 2138-2146.

Ono, S.I., L. Cai, D.J. Koropatnick, and M.G. Cherian. 2000. Radiation Exposure does not alter metallothionein III isoform expression in mouse brain. Biological Trace Element Research 74 (1): 23-30.

Zalups, R.K., and D.J. Koropatnick. 2000. Temporal changes in metallothionein gene transcription in rat kidney and liver: relationship to content and mercury metallothionein protein level. The Journal of Pharmacology and Experimental Therapeutics 295 (1): 74-82.

LEIGHTON, C.

Leighton, C., B.J. Fisher, and F. Perera. 2001. Acute radiation proctitis. Lancet 357 (9252:306): 306-307.

MACDONALD, D.R.

MYMRYK, J.S.

Turnell, A.S., R.J.A. Grand, C. Gorbea, X. Zhang, W. Wang, J.S. Mymryk, and P.H. Gallimore. 2000. Regulation of the 26S proteasome by adenovirus E1A. EMBO Journal 19 (17): 4759-4773.

Zhang, Z., M.M. Smith, and J.S. Mymryk. 2001. Interaction of the E1A oncoprotein with Yak1p, a novel regulator of yeast pseudohyphal differentiation, and related mammalian kinases. Molecular Biology of the Cell 12 (3): 699-710.

PERERA, F

Leighton, C., B.J. Fisher, and F. Perera. 2001. Acute radiation proctitis. Lancet 357 (9252:306): 306-307.

RADWAN, J.

TORCHIA, J.

Bhattacharjee, R.N., C. Underhill, and J. Torchia. 2001. Isolation of a p300/CBP cointegrator-assocated protein coactivator complex. Methods in Molecular and Cellular Biology 176: 249-260.

Underhill, C., M.S. Qutob, S.P. Yee, and J. Torchia. 2000. A novel nuclear receptor corepressor complex, N-CoR, contains components of the mammalian SWI/SNF complex and the corepressor KAP-1. Journal of Biological Chemistry 275 (51): 40463-40470.

TURLEY, E.A.

Hall, C.L., L.A. Collis, A.J. Bo, L. Lange, A. McNicol, J.M. Gerrard, and E.A. Turley. 2001. Fibroblasts require protein kinase C. activation to respond to hyaluronan with increased locomotion. Matrix Biology 20 (3): 183-192.

Tolg, C., U. Algren, and E.A. Turley. 2000. The extracellular matrix receptors CD44 and RHAMM regulate signaling of tumor cell motility and invasion. New Frontiers in Medical Sciences: Redefining Hyaluronan. G. Abatangelo, and P.H. Weigel. Amsertdam: Elsevier.

Turley, E.A. 2001. Extracellular matrix remodelling: multiple paradigms in vascular disease. Circulation Research 88 (1): 2-4.

VAN DYK, J.

Lindsay, P., J.J. Battista, and J. Van Dyk. 2001. The effect of seed anisotrophy on brachytherapy dose distributions using 125I and 103Pd. Medical Physics 28 (3): 336-345.

Van Dyk, J., and J.J. Battista. 2000. The Cobalt-60 Challenge. MDS Nordion's Teletherapy Products Newsletter 2 (1)

VENKATESAN, V.M.

VINCENT, M.D.

Okawara, G., A. Gagliardi, W.K. Evans, and The CCO PGI Lung Cancer Disease Site Group (including M.D. Vincent). 2000. The role of thoracic radiotherapy as an adjunct to standard chemotherapy in limited-stage small-cell lung cancer. Current Oncology Reports 7 (3): 162-172.

Verschraegen, C.F., T. Sittisomwong, A.P. Kudelka, E. Guedes, M. Steger, T. Nelson-Taylor, M.D. Vincent, R. Rogers, E.N. Atkinson, and J.J. Kavanagh. 2000. Docetaxel for patients with paclitaxel-resistant Mullerian carcinoma. Journal of Clinical Oncology 18 (14): 2733-2739.

WINQUIST, E.

Miller, W.H. Jr., L.M. Reyno, G.R. Loewen, S. Huan, E. Winquist, M. Moore, A. Cato 3^rd., D. Jaunakais, J.A. Truglia, S. Matthews, J. Dancey, and E. Eisenhauer. 2000. A phase I-II study of 9-cis retinoic acid and interferon-alpha2b in patients with advanced renal-cell carcinoma: an NCIC Clinical Trials Group study. Annals of Oncology 11 (11): 1387-1389.

Winquist, E., and M. Carey. 2000. Activity of docetaxel in chemoresistant gestational choriocarcinoma. Gynecologic Oncology 79 (3): 523-524.

YEE, S.P.

Summerbell, D., P.R. Ashby, O. Coutelle, D. Cox, S.P. Yee, and P.W. Rigby. 2000. The expression of Myf5 in the developing mouse embryo is controlled by discrete and dispersed enhancers specific for particular populations of skeletal muscle precursors. Development 127 (17): 3745-3757.

YU, E.

Karnas, S.J., N. Avvakumov, E. Yu, and J.J. Battista. 2001. Operational characteristics of a prototype x-ray needle device. Physics in Medicine and Biology 46 (1): 97-106.

Kotalik, J., E. Yu, B.R. Markman, and W.K. Evans. 2001. Practice guideline on prophylactic cranial irradiation in small-cell lung cancer(1). International Journal of Radiation Oncology Biology Physics 50 (2): 309-316.

Tai, P.T., E. Yu, J. Tonita, and J. Gilchrist. 2000. Merkel Cell Carcinoma of the Skin. Journal of Cutaneous Medicine and Surgery 4 (4): 186-195.